Takagi Shozo, Frukhtbeyn Stan, Chow Laurence C, Sugawara Akiyoshi, Fujikawa Kenji, Ogata Hidehiro, Hayashi Makoto, Ogiso Binnai
American Dental Association Foundation, Paffenbarger Research Center, National Institute of Standards and Technology, Gaithersburg, MD 20899, U.S.A.
J Res Natl Inst Stand Technol. 2010 Jul-Aug;115(4):267-276. doi: 10.6028/jres.115.020. Epub 2010 Aug 1.
This study reports for the first time in vitro and in vivo properties of fluorapatite (FA)-forming calcium phosphate cements (CPCs). The experimental cements contained from (0 to 3.1) mass % of F, corresponding to presence of FA at levels of approximately (0 to 87) mass %. The crystallinity of the apatitic cement product increased greatly with the FA content. When implanted subcutaneously in rats, the in vivo resorption rate decreased significantly with increasing FA content. The cement with the highest FA content was not resorbed in soft tissue, making it the first known biocompatible and bioinert CPC. These bioinert CPCs might be useful for applications where slow or no resorption of the implant is required to achieve the desired clinical outcome.
本研究首次报道了形成氟磷灰石(FA)的磷酸钙骨水泥(CPC)的体外和体内特性。实验性骨水泥含有(0至3.1)质量%的氟,对应于FA含量约为(0至87)质量%。磷灰石骨水泥产物的结晶度随FA含量的增加而显著提高。当皮下植入大鼠体内时,体内吸收率随FA含量的增加而显著降低。FA含量最高的骨水泥在软组织中未被吸收,使其成为首个已知的具有生物相容性和生物惰性的CPC。这些生物惰性CPC可能适用于需要植入物缓慢吸收或不吸收以达到预期临床效果的应用。